You are here

  • Home
  • Archive
  • Volume 71, Issue 6
  • Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis

Article info

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis

Authors

  1. Correspondence to Suzanne Arends, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, PO Box 30001, 9700 RB Groningen, s.arends@reuma.umcg.nl
View Full Text

Citation

Arends S, Grootscholten C, Derksen RH, et al
Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis
Annals of the Rheumatic Diseases 2012;71:966-973.

Publication history

  • Received July 6, 2011
  • Accepted October 9, 2011
  • First published November 29, 2011.
Online issue publication 
October 25, 2017

Article Versions

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions